Literature DB >> 19010252

Common genetic variation and human disease.

Nick Orr1, Stephen Chanock2.   

Abstract

The landscape of human genetics has changed remarkably in a relatively short space of time. The field has progressed from comparatively small studies of rare genetic diseases to vast consortia based efforts that target the inherited components of common complex diseases and which typically involve thousands of individual samples. In particular, genome wide association studies have become possible as a result of a new generation of genotyping platforms. At the time of writing, these have led to the discovery of more than 150 novel susceptibility loci across a broad spectrum of diseases, a few in genes with high biological plausibility but the majority in others that had not been considered candidates. Here, we provide an overview of the field of complex disease genetics pertaining to mapping by association and consider the many pitfalls and caveats that have arisen.

Entities:  

Mesh:

Year:  2008        PMID: 19010252     DOI: 10.1016/S0065-2660(08)00601-9

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  22 in total

1.  Incorporating age at onset of smoking into genetic models for nicotine dependence: evidence for interaction with multiple genes.

Authors:  Richard A Grucza; Eric O Johnson; Robert F Krueger; Naomi Breslau; Nancy L Saccone; Li-Shiun Chen; Jaime Derringer; Arpana Agrawal; Michael Lynskey; Laura J Bierut
Journal:  Addict Biol       Date:  2010-07       Impact factor: 4.280

2.  Genetic variants and cognitive functions in patients with brain tumors.

Authors:  Denise D Correa; Jaya Satagopan; Axel Martin; Erica Braun; Maria Kryza-Lacombe; Kenneth Cheung; Ajay Sharma; Sofia Dimitriadoy; Kelli O'Connell; Siok Leong; Sasan Karimi; John Lyo; Lisa M DeAngelis; Irene Orlow
Journal:  Neuro Oncol       Date:  2019-10-09       Impact factor: 12.300

3.  On human disease-causing amino acid variants: statistical study of sequence and structural patterns.

Authors:  Marharyta Petukh; Tugba G Kucukkal; Emil Alexov
Journal:  Hum Mutat       Date:  2015-04-06       Impact factor: 4.878

Review 4.  Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Authors:  Jeffrey N Weitzel; Kathleen R Blazer; Deborah J MacDonald; Julie O Culver; Kenneth Offit
Journal:  CA Cancer J Clin       Date:  2011-08-19       Impact factor: 508.702

Review 5.  The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.

Authors:  Saharon Rosset; Shay Tzur; Doron M Behar; Walter G Wasser; Karl Skorecki
Journal:  Nat Rev Nephrol       Date:  2011-05-03       Impact factor: 28.314

6.  MicroRNA-4516-mediated regulation of MAPK10 relies on 3' UTR cis-acting variants and contributes to the altered risk of Hirschsprung disease.

Authors:  Yang Wang; Qian Jiang; Aravinda Chakravarti; Hao Cai; Ze Xu; Wenjie Wu; Beilin Gu; Long Li; Wei Cai
Journal:  J Med Genet       Date:  2020-02-17       Impact factor: 6.318

7.  Genome-wide association studies in cancer--current and future directions.

Authors:  Charles C Chung; Wagner C S Magalhaes; Jesus Gonzalez-Bosquet; Stephen J Chanock
Journal:  Carcinogenesis       Date:  2009-11-11       Impact factor: 4.944

8.  Common SNPs in myelin transcription factor 1-like (MYT1L): association with major depressive disorder in the Chinese Han population.

Authors:  Ti Wang; Zhen Zeng; Tao Li; Jie Liu; Junyan Li; You Li; Qian Zhao; Zhiyun Wei; Yang Wang; Baojie Li; Guoyin Feng; Lin He; Yongyong Shi
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 9.  "Personalizing" academic medicine: opportunities and challenges in implementing genomic profiling.

Authors:  David J Tweardy; John W Belmont
Journal:  Transl Res       Date:  2009-10-06       Impact factor: 7.012

10.  Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade.

Authors:  Willemijn B Breunis; Eduardo Tarazona-Santos; Renee Chen; Maureen Kiley; Steven A Rosenberg; Stephen J Chanock
Journal:  J Immunother       Date:  2008 Jul-Aug       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.